```html

Lacrimation (Excess Tearing): What It Means, Why It Happens, and How to Treat It

What is Lacrimation (excess tearing)?

Lacrimation is the medical term for tearing. While a small amount of tear film is essential for eye health—lubricating the surface, providing nutrients, and protecting against infection—excess tearing (sometimes called epiphora) occurs when the volume of tears overwhelms the eye’s drainage system or when the lacrimal glands produce more fluid than needed. The result is watery eyes that may drip onto the cheek, run down the face, or cause a constantly “wet” feeling.

Most people experience occasional tearing, such as when they cut onions or get something in the eye. Chronic lacrimation, however, can be a sign of an underlying ocular or systemic condition that may require medical attention.

Common Causes

Excess tearing can arise from problems inside the eye, on its surface, or in the surrounding structures. Below are the most frequent culprits, grouped by category.

• Dry‑eye syndrome (compensatory tearing) – Paradoxically, when the eye is too dry, the lacrimal gland overproduces tears in an attempt to re‑lubricate the surface.
• Blocked tear duct (nasolacrimal duct obstruction) – Scarring, infection, or age‑related narrowing prevents normal drainage.
• Allergic conjunctivitis – Pollen, pet dander, or mold trigger inflammation that leads to watery, itchy eyes.
• Blepharitis – Inflammation of the eyelid margins interferes with the normal spread of tears.
• Eyelid malposition (ectropion or entropion) – Everted or inverted lids prevent proper tear film distribution and drainage.
• Conjunctival or corneal irritation – Foreign bodies, contact‑lens wear, or chemical exposure stimulate reflex tearing.
• Infections – Viral (e.g., adenovirus), bacterial, or fungal conjunctivitis often present with excessive tearing.
• Environmental factors – Wind, smoke, dry air, or bright light can provoke reflex tearing.
• Medications – Certain drugs (e.g., antihistamines, isotretinoin, or some glaucoma drops) can disturb tear production or drainage.
• Systemic diseases – Autoimmune disorders such as Sjögren’s syndrome, thyroid eye disease, or facial nerve palsy may affect tear dynamics.

Associated Symptoms

Excess tearing rarely occurs in isolation. The following signs often accompany lacrimation and can help pinpoint the underlying cause.

• Eye redness or bloodshot appearance
• Itching, burning, or gritty sensation
• Blurred vision that improves after blinking
• Swollen eyelids or crusting, especially after sleep
• Discharge that is clear, mucoid, or purulent
• Sensitivity to light (photophobia)
• Floating “floaters” or flashes of light (suggesting retinal involvement)
• Facial numbness or weakness (possible nerve involvement)
• Dryness or a feeling of “sand” in the eye despite tearing

When to See a Doctor

Most cases of mild tearing can be managed at home, but you should schedule an eye‑care appointment if you notice any of the following:

• Persistent tearing lasting more than a few weeks without improvement.
• Accompanying pain, severe redness, or a sudden decrease in vision.
• Discharge that is yellow, green, or thick (possible infection).
• Swelling or a palpable lump near the inner corner of the eye.
• History of trauma, surgery, or recent foreign‑body injury.
• Symptoms of an underlying systemic disease (e.g., joint pain, dry mouth, weight loss).
• Repeated episodes that interfere with daily activities, work, or driving.

Diagnosis

Eye specialists (ophthalmologists or optometrists) use a stepwise approach to determine why tears are excessive.

1. Medical History

Discussion of symptom onset, duration, triggers (allergies, wind, contact lenses), medication list, and any systemic illnesses.

2. Visual‑Acuity Test

Ensures that tearing isn’t masking a refractive problem or more serious ocular pathology.

3. External Eye Examination

Using a slit‑lamp microscope, the clinician examines eyelids, lashes, conjunctiva, cornea, and tear meniscus (the thin line of tears at the lid margin).

4. Dye Tests

• Fluorescein staining – Highlights corneal abrasions or punctate dryness.
• Lacrimal‑system irrigation (Jones test) – Saline is introduced into the puncta; the fluid’s flow is observed to locate blockages.

5. Imaging (if needed)

CT or MRI may be ordered for suspected nasolacrimal duct obstruction, tumors, or orbital disease.

6. Laboratory Tests

If an autoimmune condition is suspected, blood work (ANA, rheumatoid factor, thyroid panel, Sjögren’s antibodies) may be requested.

Treatment Options

Management depends on the root cause and severity. Strategies range from simple lifestyle changes to surgical interventions.

1. Home & Lifestyle Care

• Warm compresses – 5‑10 minutes, 2–3 times daily, help melt crusts and improve meibomian gland function (useful for blepharitis).
• Lid hygiene – Gentle scrubbing of the eyelid margin with diluted baby shampoo or commercial lid wipes.
• Artificial tears – Preservative‑free lubricating drops replenish the tear film in dry‑eye‑related tearing.
• Allergy control – Antihistamine eye drops, oral antihistamines, or nasal steroid sprays reduce allergic lacrimation.
• Humidifier use – Adds moisture to dry indoor air.
• Protective eyewear – Goggles in windy or dusty environments prevent reflex tearing.

2. Medications

• Topical anti‑inflammatories (e.g., corticosteroid eye drops) for severe allergic or inflammatory conjunctivitis – short‑term use only.
• Antibiotic eye drops or ointments for bacterial infections.
• Oral tetracyclines (doxycycline) – Low‑dose therapy improves meibomian gland secretions in chronic blepharitis.
• Cyclosporine A (Restasis) or lifitegrast (Xiidra) – Prescription drops that boost natural tear production in dry‑eye disease.

3. Procedural & Surgical Interventions

• Punctal plugs – Small silicone or collagen devices inserted into the tear‑draining puncta to retain tears on the ocular surface (useful for dry-eye‑related epiphora).
• Dacryocystorhinostomy (DCR) – Surgical creation of a new drainage pathway between the lacrimal sac and nasal cavity for chronic nasolacrimal duct obstruction.
• Nasolacrimal duct stenting – Temporary tube placed to keep the duct open while healing occurs.
• Eyelid surgery (e.g., canthoplasty, ectropion correction) to correct malposition that interferes with tear flow.
• Botulinum toxin injection – Rarely used to reduce hyperactive lacrimal glands in refractory cases.

4. Addressing Underlying Systemic Disease

Effective control of conditions such as thyroid eye disease, Sjögren’s syndrome, or facial nerve palsy often improves tearing as part of comprehensive disease management.

Prevention Tips

While some causes (age‑related duct narrowing, genetics) cannot be fully prevented, many triggers are modifiable.

• Maintain good eyelid hygiene; clean eyelid margins daily, especially if you wear contact lenses.
• Limit exposure to known allergens; keep windows closed during high pollen counts and use air filters.
• Wear protective eyewear during activities that generate wind, dust, or chemicals.
• Stay hydrated and follow a balanced diet rich in omega‑3 fatty acids (found in fish, flaxseed) to support healthy meibomian glands.
• Take breaks during prolonged screen time; follow the “20‑20‑20” rule to reduce eye strain.
• If you use eye drops regularly, choose preservative‑free formulas to avoid chronic irritation.
• Schedule routine eye exams (at least every 1–2 years) to catch early lid or canalicular changes.

Emergency Warning Signs

Key Take‑aways

Lacrimation, or excess tearing, is usually a symptom rather than a disease itself. Understanding the cause—whether it’s a blocked duct, allergy, dry‑eye paradox, or eyelid abnormality—guides effective treatment. Most cases respond well to simple home measures and topical therapies, but persistent or painful tearing warrants professional evaluation. Early diagnosis and appropriate management help protect eye health and prevent complications.

References:

• Mayo Clinic. “Epiphora (excessive tearing).” Updated 2023.
• American Academy of Ophthalmology. “Dry Eye.” 2024.
• Cleveland Clinic. “Blocked Tear Duct (Nasolacrimal Duct Obstruction).” 2022.
• National Eye Institute (NEI). “Allergic Conjunctivitis.” 2023.
• World Health Organization. “Global Guidelines for Eye Health.” 2021.
• J. Frishman et al., “Management of Chronic Epiphora,” *Ophthalmology* 2022;129(4):505‑514.

```